"The EDSS has a number of limitations and may also measure changes that are not related to MS, such as older age and multiple ...

Contineum Therapeutics has concluded the targeted enrolment of 168 subjects in its Phase II trial of M1 receptor antagonist ...

After getting through a significant difficulty, many of us reject being described in favorable terms. Why don't we want to ...

A team of doctors in Mumbai treated a 24-year-old engineering student who was suffering from multiple sclerosis, a chronic disease that affects the nervous system. For the patient, Sushant Chavan, ...

The world’s largest study of proteins circulating the human body will begin in the UK this month, with the aim of pinpointing how diseases develop and paving the way for simple blood tests to detect ...

Largest ever protein study set to revolutionise cancer and dementia tests - Tens of millions of pounds in investment is being provided by the group of firms which includes AstraZenecaa and Pfizer ...

For patients with relapsed or refractory multiple myeloma, talquetamab plus teclistamab shows response in a high percentage ...

SPRINGFIELD, Ill. – The Illinois Department of Public Health (IDPH) has approved four new conditions for treatment with ...

LOUISVILLE, Ky. (WDRB) -- Kentuckians suffering from chronic pain and other serious health conditions are now able to get a medical marijuana card — but the new option comes with hurdles. To qualify ...

Columnist Ben Hofmeister explains a handy acronym that's helped him and can help you motivate yourself with MS.

Immunic Therapeutics says it's "on track" in its MS clinical trials of vidofludimus calcium, with CALLIPER top-line data ...